MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewed
Comparative therapeutic potential of ALX-0171 and palivizumab against RSV clinical isolate infection of well-differentiated primary pediatric bronchial epithelial cell cultures
L. Broadbent, H. Guo Parke, L. J. Ferguson…·U. F. Power
This study compares the therapeutic efficacy of ALX-0171 and palivizumab against RSV infection in a human bronchial epithelial cell model, showing ALX-0171 is more potent at neutralizing virus but less effective at reducing viral genomic copies.
DOI 10.1128/aac.02034-19